On October 25, 2024, we proudly hosted the inaugural Internal Medicine Forum at the Sheraton Sharjah, a landmark event for Al Qassimi Hospital. This highly successful conference brought together 50 leading medical experts, fostering collaboration and knowledge exchange. The program featured four distinguished speakers who delivered impactful lectures on critical topics in internal medicine, sparking engaging discussions and insights. Sponsored by Bayer, the event set a high standard for future forums, combining academic excellence with professional networking in a sophisticated setting.

Internal Medicine Forum
Al Qassimi Hospital

25 October 2024 at Sheraton Sharjah, Sharjah

Treatment and Preventive Strategies in Venous Thromboembolic Diseases (VTE)

Dr. Raja Wagar, the first speaker at the Internal Medicine Forum 2024, delivered an exceptional lecture on "Treatment and Preventive Strategies in Venous Thromboembolic Diseases (VTE)." His presentation provided a comprehensive overview of cutting-edge advancements in VTE management, emphasizing innovative preventive measures and treatment approaches. Dr. Wagar's expertise and engaging delivery captivated the audience, offering valuable insights that sparked meaningful discussions among the attending medical professionals.

Data of pulmonary Embolism in
Al Qassimi Hospital

Dr. Farah Al-Khaleefa, the second speaker at the Internal Medicine Forum 2024, presented an enlightening lecture titled "Data on Pulmonary Embolism in Al Qassimi Hospital." Dr. Al-Khaleefa shared valuable insights into local case studies, highlighting trends, challenges, and outcomes in managing pulmonary embolism within the hospital. His data-driven approach offered a deeper understanding of the condition's impact on patient care and emphasized the importance of evidence-based strategies tailored to the region. The lecture was both informative and thought-provoking, leaving a lasting impression on the audience.

⁠Evolving Role of Finerenone in management of CKD in T2D

Dr. Shaikh Iman, the third speaker at the Internal Medicine Forum 2024, delivered an impactful lecture titled "Evolving Role of Finerenone in the Management of CKD in T2D." His presentation explored the groundbreaking potential of Finerenone in addressing chronic kidney disease (CKD) in patients with type 2 diabetes (T2D). Dr. Iman provided an in-depth analysis of clinical data, shedding light on the drug's effectiveness and its transformative role in improving patient outcomes. His expertise and engaging delivery captivated the audience, offering new perspectives on managing these complex conditions.

⁠Aldosterone and Cardio Metabolic Diseases

Dr. Ajith Kumar, the final speaker at the Internal Medicine Forum 2024, concluded the event with a compelling lecture titled "Aldosterone and Cardio-Metabolic Diseases." His presentation delved into the intricate role of aldosterone in the pathophysiology of cardio-metabolic disorders, highlighting its implications for diagnosis, management, and treatment strategies. Dr. Kumar's in-depth knowledge and engaging delivery captivated the audience, providing a thought-provoking end to the conference and inspiring further discussions among the attending medical professionals.